Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease

Earlier studies showed that the Val66Met polymorphisms of the brain-derived neurotrophic factor differentially affect gray matter volume and brain region activities. This study used resting positron emission tomography to investigate the relationship between the polymorphisms of Val66Met and the regional cerebral metabolic rate in the brain. We analyzed the positron emission tomography images of 215 patients from the Alzheimer's Disease Neuroimaging Initiative and found significant differences in the parahippocampal gyrus, superior temporal gyrus, prefrontal cortex, and inferior parietal lobule when comparing Met carriers with noncarriers among both the normal controls and those with mild cognitive impairment. For those with Alzheimer's disease, we also found additional differences in the bilateral insula between the carriers and noncarriers.

[1]  Daniel S Pine,et al.  BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents , 2010, NeuroImage.

[2]  Norihiro Sadato,et al.  Smaller insula and inferior frontal volumes in young adults with pervasive developmental disorders , 2010, NeuroImage.

[3]  Irwin P. Levin,et al.  The impact of prior risk experiences on subsequent risky decision-making: The role of the insula , 2010, NeuroImage.

[4]  L. Passamonti,et al.  The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: An imaging genetic study , 2010, Behavioural Brain Research.

[5]  et al.,et al.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2009, NeuroImage.

[6]  C. Montag,et al.  The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression , 2009, Psychological Medicine.

[7]  A Pickles,et al.  Additive effect of BDNF and REST polymorphisms is associated with improved general cognitive ability , 2008, Genes, brain, and behavior.

[8]  Kiyotaka Nemoto,et al.  Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity , 2008, Neuroscience Research.

[9]  P Rabbitt,et al.  Brain‐derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly , 2008, Genes, brain, and behavior.

[10]  C. Siao,et al.  Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior , 2006, Science.

[11]  S. Poduslo,et al.  Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease , 2006, Journal of Medical Genetics.

[12]  Margit Burmeister,et al.  BDNF Val66Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects , 2006, Biological Psychiatry.

[13]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[14]  J. Gorski,et al.  Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor , 2004, The Journal of Neuroscience.

[15]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[16]  H. Soininen,et al.  Hippocampus and entorhinal cortex in mild cognitive impairment and early AD , 2004, Neurobiology of Aging.

[17]  K. Herholz,et al.  Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study , 2004, Psychiatry Research: Neuroimaging.

[18]  M. Egan,et al.  Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance , 2003, The Journal of Neuroscience.

[19]  Nick C Fox,et al.  Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Blass.  The Mitochondrial Spiral: An Adequate Cause of Dementia in the Alzheimer's Syndrome , 2000, Annals of the New York Academy of Sciences.

[21]  R. Faull,et al.  Brain-derived neurotrophic factor is reduced in Alzheimer's disease. , 1997, Brain research. Molecular brain research.

[22]  R A Crowther,et al.  Tau Proteins and Neurofibrillary Degeneration , 1991, Brain pathology.

[23]  D. Benson,et al.  The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. , 1983, Archives of neurology.

[24]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[25]  O. Kitis,et al.  BDNF Gene Val66met Polymorphism Associated Grey Matter Changes in Human Brain , 2005 .

[26]  Robert L. Burch,et al.  NGF deprivation-induced gene expression: after ten years, where do we stand? , 2004, Progress in brain research.

[27]  M. Riva,et al.  Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease , 2002, Molecular Psychiatry.